Stem cell study for autism
Part of Mental health clinical trials.
This trial tests a stem cell treatment for children and adults with Autism Spectrum Disorder. It aims to see if this treatment is safe and if it can help improve autism symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 6 years old and weigh at least 17 kg (about 37 pounds)
- Have a confirmed diagnosis of Autism Spectrum Disorder
- Either not taken any psychiatric drugs in the past 3 months or be on a stable dose of the same drug for at least 3 months
- Agree to be part of the study, along with a parent or guardian if you are a child
- Not have an active infection, a history of seizures in the last 6 months, or other serious health conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of experimental treatments for children with autism spectrum disorder. It may help if your child has not had stem cell or glutathione therapy before.
This is an early-stage study exploring a new experimental treatment for autism spectrum disorder (ASD). Researchers will work with your child and family to test whether this approach is safe and how it might help with autism symptoms.
This study tests whether a combination of stem cell therapy, gut microbiome restoration (using specially prepared stool), and dietary changes can improve autism symptoms, communication, social behavior, and digestive issues. Researchers believe gut health and immune system problems may contribute to autism, and this trial explores whether treating these areas helps.
This trial tests a new brain stimulation therapy (called NeuroCytotron) to see if it helps children with autism who have some verbal communication. The goal is to help the brain form new connections and improve symptoms.
This study tests an experimental medication called TB006 for adults with autism. It aims to see if it can help reduce symptoms. Participants must be 18–35, have moderate-to-severe autism, and have a caregiver who can join them.
This study combines three treatments—light therapy at acupoints, your child's own platelet-rich plasma, and umbilical cord exosomes—to see if they can help improve symptoms of autism spectrum disorder. It's for children ages 3 to 12 with an autism diagnosis, and you'll work closely with the study team.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.